Biohaven Ltd. (BHVN) Free Cash Flow
Biohaven Ltd. (BHVN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2022-12-31 | -$338.76M |
| 2023-12-31 | -$334.77M |
| 2024-12-31 | -$586.50M |
| 2025-12-31 | -$610.15M |
How BHVN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| IOVA | Iovance Biotherapeutics Inc. | -$336.24M |
| AGIO | Agios Pharmaceuticals Inc. | -$377.29M |
| NTLA | Intellia Therapeutics Inc. | -$395.87M |
| DNLI | Denali Therapeutics Inc. | -$422.10M |
| RARE | Ultragenyx Pharmaceutical Inc. | -$487.00M |
These are five companies in the same sector as BHVN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Biohaven Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("BHVN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BHVN | $15.41 | -4.40% | 2.89M |
| 3 | ||||
| 4 | ||||
| 5 |